PharmaEngine, Inc. (Stock Code: 4162.TWO)

Climate Impact & Sustainability Data (2022, 2023)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:≈129 tCO2e/year (Scope 1 & 2)

Scope 1 Emissions:≈56 tCO2e/year

Scope 2 Emissions:≈73 tCO2e/year

Total Energy Consumption:≈145,048 kWh/year (estimated)

Water Consumption:962.7 m3/year

Waste Generated:111.2 kg/year

ESG Focus Areas

Environmental Sustainability
Social Responsibility
Integrity Management

Environmental Achievements

Conducted Scope 1 and Scope 2 carbon emissions inventory process
Procured office electronic equipment with “environmentally sustainable” certification stickers
Reduced carbon dioxide emissions per capita by more than 5% per year (goal)

Social Achievements

Held “World Pancreatic Cancer Day” to raise awareness
Collaborated with medical facilities, schools, and held group meetings for patients to share information on pancreatic cancer
Strengthened employee training on human rights issues, information security, and insider trading prevention
Hosted 6 health education seminars in collaboration with medical institutions
Participated in Sanzhi Beach Cleaning event

Governance Achievements

Established a “Sustainability Promoting Taskforce”
Included topics related to climate change issues in board meetings
Obtained ISO 27001 Information Security Management System certification in January 2023
No incidents of corruption or bribery

Climate Goals & Targets

Long-term Goals:

Include net zero emissions as a long-term development goal

Medium-term Goals:

Increase the ratio of green packaging of the Company’s products
Create a new experimental model of energy conservation and carbon reduction

Short-term Goals:

Reduce carbon dioxide emissions per capita by more than 5% per year
Reduce water consumed per capita by at least 0.5% annually
Reduce total weight of waste by at least 2% annually

Environmental Challenges

Climate change related risks (policy and regulatory, technological, transformational, market, reputation, physical, long-term)
Supply chain disruptions due to extreme weather events
Cybersecurity risks

Mitigation Strategies

Developed greenhouse gas emission reduction policies
Implemented water reduction policy
Waste reduction policy
Developed Business Continuity Plan for drug supply disruptions
Introduced green packaging material ideas
Created a new experimental model of energy conservation and carbon reduction
Obtained ISO 27001 certification for information security

Supply Chain Management

Supplier Audits: 4 GxP supplier capability assessments before cooperation; 2 scheduled audits with ESG-related issues

Responsible Procurement

Quality agreements with critical vendors
Approved vendors list
Regular audits of vendors

Climate-Related Risks & Opportunities

Physical Risks

Typhoons, floods, droughts
Elevated sea level
Long-term heat waves

Transition Risks

Climate change-related policy actions (carbon pricing)
Technological changes
Market shifts

Opportunities

Enhance resource utilization efficiency
Promote green consumption
Promote low-carbon products and services
Apply AI to reduce animal experiments

Reporting Standards

Frameworks Used: GRI Standards 2016, SASB Standards, TCFD

Certifications: ISO 27001

Third-party Assurance: PricewaterhouseCoopers (PwC) Taiwan (limited assurance)

UN Sustainable Development Goals

SDG 3
SDG 4
SDG 7
SDG 8
SDG 9
SDG 10
SDG 12
SDG 13
SDG 14
SDG 16
SDG 17

The report mentions alignment with several SDGs throughout the document, but lacks specific details on how initiatives contribute to each goal.

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:≈109 tCO2e/year (Scope 1 & 2)

Scope 1 Emissions:≈42 tCO2e/year

Scope 2 Emissions:≈67 tCO2e/year

Scope 3 Emissions:Not disclosed

Renewable Energy Share:Not disclosed

Total Energy Consumption:≈138,925 kWh/year (estimated based on 2-year average)

Water Consumption:971.44 tons/year

Waste Generated:201.2 kg/year

Carbon Intensity:Not disclosed